BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 22008208)

  • 1. Dyspnoea at the end of life: instrument development and validation-the CONFORTO Strategy.
    Teixeira ICA; Carvas AMP; Silva RBD; Borges E; Corrêa-Faria P; Rabahi MF
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e1103-e1109. PubMed ID: 35473755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laryngeal widening and adequate ventilation by expiratory pressure load training improve aerobic capacity in COPD: a randomised controlled trial.
    Miki K; Tsujino K; Fukui M; Miki M; Kitajima T; Sumitani H; Hashimoto K; Yokoyama M; Hashimoto H; Nii T; Matsuki T; Kida H;
    Thorax; 2023 Dec; 79(1):23-34. PubMed ID: 37696622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary rehabilitation and physical interventions.
    Troosters T; Janssens W; Demeyer H; Rabinovich RA
    Eur Respir Rev; 2023 Jun; 32(168):. PubMed ID: 37286219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen Extraction Based on Inspiratory and Expiratory Gas Analysis Identifies Ventilatory Inefficiency in Chronic Obstructive Pulmonary Disease.
    Miki K; Tsujino K; Maekura R; Matsuki T; Miki M; Hashimoto H; Kagawa H; Kawasaki T; Kuge T; Kida H
    Front Physiol; 2021; 12():703977. PubMed ID: 34393822
    [No Abstract]   [Full Text] [Related]  

  • 5. Motor Pathophysiology Related to Dyspnea in COPD Evaluated by Cardiopulmonary Exercise Testing.
    Miki K
    Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33670051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyspnea and the Varying Pathophysiologic Manifestations of Chronic Obstructive Pulmonary Disease Evaluated by Cardiopulmonary Exercise Testing With Arterial Blood Analysis.
    Kagawa H; Miki K; Kitada S; Miki M; Yoshimura K; Oshitani Y; Nishida K; Sawa N; Tsujino K; Maekura R
    Front Physiol; 2018; 9():1293. PubMed ID: 30333757
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy.
    Ekström M; Ahmadi Z; Bornefalk-Hermansson A; Abernethy A; Currow D
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD006429. PubMed ID: 27886372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized pulmonary rehabilitation and occupational therapy based on cardiopulmonary exercise testing for patients with advanced chronic obstructive pulmonary disease.
    Maekura R; Hiraga T; Miki K; Kitada S; Miki M; Yoshimura K; Yamamoto H; Kawabe T; Mori M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1787-800. PubMed ID: 26366071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ghrelin treatment on exertional dyspnea in COPD: an exploratory analysis.
    Miki K; Maekura R; Nagaya N; Miki M; Kitada S; Yoshimura K; Mori M; Kangawa K
    J Physiol Sci; 2015 May; 65(3):277-84. PubMed ID: 25724656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ghrelin treatment on exercise capacity in underweight COPD patients: a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment.
    Miki K; Maekura R; Nagaya N; Kitada S; Miki M; Yoshimura K; Tateishi Y; Motone M; Hiraga T; Mori M; Kangawa K
    BMC Pulm Med; 2013 Jun; 13():37. PubMed ID: 23758800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD.
    Peters MM; Webb KA; O'Donnell DE
    Thorax; 2006 Jul; 61(7):559-67. PubMed ID: 16467067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exertional desaturation in patients with chronic obstructive pulmonary disease.
    Panos RJ; Eschenbacher W
    COPD; 2009 Dec; 6(6):478-87. PubMed ID: 19938972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventilatory Inefficiency and Exertional Dyspnea in Early Chronic Obstructive Pulmonary Disease.
    Neder JA; Berton DC; Müller PT; Elbehairy AF; Rocha A; Palange P; O'Donnell DE;
    Ann Am Thorac Soc; 2017 Jul; 14(Supplement_1):S22-S29. PubMed ID: 28345959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oxygen on exertional dyspnoea and exercise performance in patients with chronic obstructive pulmonary disease.
    Miki K; Maekura R; Hiraga T; Kitada S; Miki M; Yoshimura K; Tateishi Y
    Respirology; 2012 Jan; 17(1):149-54. PubMed ID: 22008208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exertional acidotic responses in idiopathic pulmonary fibrosis: the mechanisms of exertional dyspnea.
    Miki K; Maekura R; Miki M; Kitada S; Yoshimura K; Tateishi Y; Mori M
    Respir Physiol Neurobiol; 2013 Feb; 185(3):653-8. PubMed ID: 23246672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidosis and raised norepinephrine levels are associated with exercise dyspnoea in idiopathic pulmonary fibrosis.
    Miki K; Maekura R; Hiraga T; Hashimoto H; Kitada S; Miki M; Yoshimura K; Tateishi Y; Fushitani K; Motone M
    Respirology; 2009 Sep; 14(7):1020-6. PubMed ID: 19740262
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.